Suppr超能文献

为体重不足20公斤的儿童植入支架治疗复发性和原发性主动脉缩窄。

Implantation of stents for treatment of recurrent and native coarctation in children weighing less than 20 kilograms.

作者信息

Schaeffler Rainer, Kolax Tanja, Hesse Carola, Peuster Matthias

机构信息

Clinic for Congenital Heart Defects, Heart- and Diabetes-Center Nordrhein Westfalen, Bad Oeynhausen, Germany.

出版信息

Cardiol Young. 2007 Dec;17(6):617-22. doi: 10.1017/S1047951107001448. Epub 2007 Oct 31.

Abstract

We report our experience with implantation of stents for treatment of recurrent and native aortic coarctation in children weighing less than 20 kilograms. We treated 9 such patients between March, 2003, and January, 2006. In 2 patients, the coarctation had not previously been treated, while in 7 it had recurred after surgery. The patients had a median weight of 14 kilograms, with a range from 5.5 to 19 kilograms. Balloon dilation was needed in 1 patient before the stent was implanted. We used Palmaz Genesis XD stents in 7 patients, these having lengths from 19 to 29 millimetres, 1 Palmaz Genesis 124P stent, and 1 peripheral JoStent with a diameter of 6 to 12 millimetres. Implantation was effective in all patients. Immediately after implantation, the mean peak systolic gradient decreased from 30 millimetres of mercury, the range having been 15 to 50 mm, to 3 millimetres of mercury, with the final range from zero to 10 mm. There were no complications, with no observations of aneurysms, dissections, or dislocated stents. In 1 patient, the peripheral pulse was weak secondary to arterial access, but treatment with Heparin led to complete resolution. It was necessary to re-dilate the stent in another patient, while 2 others are scheduled for redilation because of growth-related restenosis. Our findings suggest that implantation of stents can produce excellent relief of the gradient produced by recurrent or native coarctation. The process is safe and effective in patients weighing less than 20 kilograms.

摘要

我们报告了在体重不足20公斤的儿童中植入支架治疗复发性和原发性主动脉缩窄的经验。2003年3月至2006年1月期间,我们治疗了9例此类患者。其中2例患者此前未接受过主动脉缩窄治疗,7例患者在手术后出现了缩窄复发。患者的中位体重为14公斤,范围在5.5至19公斤之间。1例患者在植入支架前需要进行球囊扩张。我们对7例患者使用了Palmaz Genesis XD支架,其长度为19至29毫米,1例患者使用了Palmaz Genesis 124P支架,1例患者使用了直径为6至12毫米的外周JoStent支架。所有患者的植入均有效。植入后,平均收缩期峰值压差立即从30毫米汞柱(范围为15至50毫米汞柱)降至3毫米汞柱,最终范围为0至10毫米汞柱。未出现并发症,未观察到动脉瘤、夹层或支架移位。1例患者因动脉穿刺导致外周脉搏微弱,但肝素治疗后完全缓解。另1例患者需要再次扩张支架,还有2例患者因生长相关的再狭窄计划进行再次扩张。我们的研究结果表明,植入支架可以显著缓解复发性或原发性主动脉缩窄产生的压差。该方法在体重不足20公斤的患者中安全有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验